Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: A Plethora Of Big Rounds, Led By Gossamer's $230m Series B

Jul 31 2018

• By Mandy Jackson

Finance Watch

Related Content

A Virtuous Cycle: What The Immuno-Oncology Revolution Means For Other Disease Areas

Jan 31 2018

FINANCE ROUNDUP: Will VC Be Last Man Standing If Biotech Bubble Bursts?

Sep 29 2015

AbbVie Goes Boldly Into Immuno-Neurology With Alector

Oct 24 2017

VC-Run Dementia Discovery Fund Plays It Safe With First Investment

Jan 07 2016

VC Roundup: Infectious Disease Startup Snags $150m And Former Biogen CEO Scangos

Jan 08 2017

An Inflammatory Deal: Bristol Commits Up To $2.3bn To Buy IFM Therapeutics

Aug 04 2017

Presage eyes drug, diagnostic development with fresh cash from Celgene

Mar 07 2013

Finance Watch: Mysterious Gossamer Raises $100m As VC Deals Surge Ahead of J.P. Morgan

Jan 06 2018

1ST Bio Bets On BBB-Penetrating C-ABL Inhibitor As Potential Disease-Modifying Parkinson's Drug

Jun 01 2018

Mehta Analysis: China, A Populist Pharma Power

Jul 20 2018

Celgene diversifies with $7.2bn Receptos buy

Jul 15 2015

Presage Biosciences Inc.

Apr 23 2013

Related Companies

Gossamer Bio, Inc.

Ascentage Pharma Group Corporation

Alector, Inc.

Receptos, Inc.

Bristol Myers Squibb Company

I-Mab

AbbVie Inc.

Merck & Co., Inc.

Sutro Biopharma, Inc.

HotSpot Therapeutics, Inc.

Neuraly, Inc.

IFM Tre

IFM Therapeutics

Bristol Myers Squibb Company

Sanofi

Takeda Pharmaceutical Co. Ltd.

Presage Biosciences

Additional Topics

Financing Business Strategies Deals Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window